Amerigen Pharmaceuticals
197 Route 18 South, Suite 306 N
East Brunswick
New Jersey
08816
United States
Tel: 732-993-9827
Website: http://www.amerigenpharma.com/
22 articles about Amerigen Pharmaceuticals
-
Amerigen Announces U.S. FDA Approval For Generic Penicillamine 250 mg Capsules
5/8/2019
The first generic version of Penicillamine Capsules USP is now approved in the U.S.
-
Amerigen's Petition Leads to U.S. Zytiga Patent Invalidation
1/18/2018
Amerigen was represented during the hearings on IPR2016-00286 by William Hare of McNeely Hare & War LLP.
-
Amerigen and Biophore Collaborate on Penicillamine Generics
10/25/2017
Amerigen Pharma and Biophore today announced that they are collaborating to bring a generic version of Valeant's Cuprimine and other penicillamine based generic products to the U.S. market using active pharmaceutical ingredient supplied by Biophore from India.
-
Amerigen Pharmaceuticalsen Believes That It Is A First Applicant To File An Abbreviated New Drug Application ("ANDA") For Certain Strengths Of Namzaric Containing A "Paragraph IV" Patent Certification Under The Provisions Of The Hatch-Waxman Act
9/5/2017
-
Amerigen Pharmaceuticals Announces Final Approval From FDA For Generic Version Of Temodar
8/18/2016
-
Amerigen Pharmaceuticals Announces Final Approval From FDA For Generic Version Of Lysteda
8/2/2016
-
Amerigen Pharmaceuticals And DIPHARMA Announce First Regulatory Submission For Miglustat 100mg Capsules
1/12/2016
-
Amerigen Pharmaceuticals Announces Tentative Approval Of Generic Toviaz
4/30/2015
-
Amerigen Pharmaceuticals Announces Tentative Approval Of Generic Bystolic
4/17/2015
-
Fosun Pharma To Invest In Amerigen Pharmaceuticals
1/9/2015
-
Amerigen Pharmaceuticals And The Ningbo MENOVO Pharmaceutical Co.,LTD., Today Announced They Had Entered Into A Collaboration Agreement Regarding The Development Of Generic Pharmaceuticals, Primarily Targeting The United States Market
8/27/2014
-
Amerigen Pharmaceuticals Announces That Its Chinese Subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., Has Received Chinese FDA (CFDA) Approval And Has Subsequently Launched Its Generic Mecobalamin 0.5 Mg Tablets Into The China Domestic Market
8/20/2014
-
Amerigen Pharmaceuticals Announces That Its ANDA For Carbidopa 25mg Tablets Has Received Final Approval From The FDA
3/12/2014
-
Sinochem Jiangsu to Distribute Suzhou Amerigen Pharmaceuticals Drug in China
9/27/2013
-
Amerigen Pharmaceuticals Today Announced Its Chinese Subsidiary, Suzhou Amerigen Pharmaceuticals Co., Ltd., Had Entered Into a Marketing and Distribution Agreement With Sinochem Jiangsu Pharmaceutical Co., Ltd. Regarding Amerigen's Generic Mecobalamin 0.5
9/26/2013
-
Amerigen Pharmaceuticals Today Announced It Had Entered Into a Collaboration Agreement With Forest Laboratories, Inc. Regarding the Development of a Number of Specialty Generic Products.
7/31/2013
-
Amerigen Pharmaceuticals Announces ANDA Filing and BYSTOLIC(R) Patent Challenge
3/16/2012
-
Amerigen Pharmaceuticals Announces Two China-US Deals
1/13/2012
-
Amerigen Pharmaceuticals and VIWA Pharmaceutical Company Today Jointly Announce the Signing of a Memorandum of Understanding (MOU) Setting Out Their Intention to Establish a Joint Venture to Develop and Register a Range of Branded Generic Medicines for Sa
1/12/2012
-
Amerigen Pharmaceuticals and the Shanghai Fosun Omni Pharmaceutical Company Enter Into Collaboration Agreement for the Development of Generic Oral Controlled Release Products
1/11/2012